MyoPro 2+ Series
Upper limb paralysis/weakness (Stroke, BPI, TBI, SCI, CP)
CommercialActive
Key Facts
Indication
Upper limb paralysis/weakness (Stroke, BPI, TBI, SCI, CP)
Phase
Commercial
Status
Active
Company
About Myomo
Myomo's mission is to restore function and independence to individuals with upper limb paralysis through its innovative MyoPro powered orthosis. The company has achieved commercial-stage status, securing critical Medicare reimbursement and building a growing body of clinical evidence to support adoption. Its strategy centers on a B2B2C model, expanding insurance coverage, and directly engaging clinicians and therapists to identify eligible patients within a large, underserved neurological rehabilitation market.
View full company profile